Cargando…
Commentary on the 2020 update of the KDOQI clinical practice guideline for nutrition in chronic kidney disease
Autores principales: | Lambert, Kelly, Bahceci, Su, Harrison, Harriet, Chan, Maria, Scholes‐Robertson, Nicole, Johnson, David W., Yip, Adela, Viecelli, Andrea K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303594/ https://www.ncbi.nlm.nih.gov/pubmed/35118773 http://dx.doi.org/10.1111/nep.14025 |
Ejemplares similares
-
Perceptions and use of the national kidney foundation KDOQI guidelines: a survey of U.S. renal healthcare providers
por: Estrella, Michelle M, et al.
Publicado: (2013) -
Commentary on the ASH 2020 guidelines on cognitive screening and intervention in sickle cell disease
por: Hoyt, Catherine R., et al.
Publicado: (2023) -
A commentary on the 2015 Canadian Clinical Practice Guidelines in glutamine supplementation to parenteral nutrition
por: Leguina-Ruzzi, Alberto
Publicado: (2016) -
The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease
por: Portolés, José, et al.
Publicado: (2013) -
Commentary on Indian Menopause Society Guidelines
por: Cherian, Kripa Elizabeth, et al.
Publicado: (2020)